4,5-diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)

  • John J. Talley
  • , Stephen R. Bertenshaw
  • , David L. Brown
  • , Jeffery S. Carter
  • , Mathew J. Graneto
  • , Carol M. Koboldt
  • , Jaime L. Masferrer
  • , Bryan H. Norman
  • , D. Joseph Rogier
  • , Ben S. Zweifel
  • , Karen Seibert

Research output: Contribution to journalReview articlepeer-review

34 Scopus citations

Abstract

A series of methysulfonyl or sulfonamido substituted 4,5-diaryloxazole were prepared and evaluated for their ability to inhibit the inducible form of cyclooxygenase (COX-2) in vitro and in vivo. Several unique substitution patterns were identified that led to potent and selective inhibitors of COX- 2. In general, 2-trifluoromethly-4,5-diaryloxazoles substituted with a methylsulfonyl or sulfonamido group were particularly potent inhibitors. One of the more potent compounds with a selectivity for COX-2 of about 800 fold was 4b (SC-299). SC-299, a highly fluorescent molecule, may be useful for spectroscopic studies on preferential inhibitor binding to COX-2.

Original languageEnglish
Pages (from-to)199-208
Number of pages10
JournalMedicinal Research Reviews
Volume19
Issue number3
DOIs
StatePublished - 1999

Keywords

  • Anti-inflammatory
  • COX-2
  • COX-2 inhibitors
  • Cyclooxygenase-2
  • Diaryloxazole
  • Inflammation

Fingerprint

Dive into the research topics of '4,5-diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)'. Together they form a unique fingerprint.

Cite this